Safely and Effectively Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Sleep Apnea

Faculty

John M. Dopp, PharmD, MS, Associate Professor, School of Pharmacy; clinical pharmacist, Wisconsin Sleep Center; University of Wisconsin-Madison in Madison, Wisconsin

Educational Objectives

At the completion of this activity, the participant will be able to:

• Describe the incidence, etiology, and risk factors associated with excessive daytime sleepiness (EDS) in those with narcolepsy and obstructive sleep apnea (OSA)
• Identify the recommended treatments for EDS associated with narcolepsy and OSA, including pharmacologic and nonpharmacologic options
• Evaluate clinical safety and efficacy data for emerging therapies, including mechanisms of action and potential adverse effects
• Explain the role of the pharmacist in identifying and treating EDS in those with narcolepsy and OSA

Target Audience: Community pharmacists

Activity type: Application

Release date: September 16, 2019

Expiration date: September 16, 2020

Estimated time to complete activity: 2.0 hours

Fee: This lesson is offered for free at www.pharmacytimes.org